Permits school bus driver to administer epinephrine to student in emergency under certain circumstances.
Impact
The bill introduces important changes to how emergencies involving allergic reactions are handled in school transportation settings. By allowing school bus drivers to administer epinephrine, it is expected that response times to severe allergic reactions will decrease, which can significantly affect a student's health outcomes. Furthermore, it emphasizes the necessity for training to ensure that bus drivers can safely administer epinephrine using pre-filled auto-injectors. This component not only supports rapid medical response but also fosters a more health-conscious environment in schools.
Summary
Senate Bill 155 permits qualified school bus drivers to administer epinephrine to students in emergency situations involving anaphylaxis. The bill outlines specific requirements that must be met before a school bus driver can perform such an action, including obtaining written authorization from the student's parent or guardian, as well as a standing order from a physician or advanced practice nurse. This legislation aims to enhance the safety and well-being of students who may experience severe allergic reactions while being transported on school buses.
Contention
While the supporters of SB 155 argue that it is a crucial step towards improving student health safety, opponents may raise concerns over potential risks and the adequacy of the provided training. The bill also includes provisions stating that neither the school district nor the bus driver would incur liability when responding in good faith to emergencies, which some may perceive as diluting accountability. Therefore, discussions may revolve around balancing the need for immediate health interventions with ensuring responsible implementation and training protocols.